Research blend of cagrilintide and semaglutide for metabolic-pathway studies.
Cagrilintide + Semaglutide is a research-grade combination of an amylin analogue and a GLP-1 receptor agonist supplied in a single lyophilized vial — used in laboratory studies of co-receptor signalling and metabolic homeostasis. Sealed, third-party HPLC verified. Research and laboratory use only.
For research and laboratory use only · Not for human or animal consumption